Ovid Looks To Epilepsy – And Beyond – For Candidate OV350

 
• By Alaric DeArment
  
Ovid announced its third quarter 2023 earnings • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Earnings

More from Business